MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 401 to 420 of 166,322 approvalsPage 21 of 8317

Ibuprofen Suspension Drops

Approval Number: 国药准字H20254095
Registration: May 13, 2025
山东新华制药股份有限公司

Magnesium Sulfate Injection

Approval Number: 国药准字H20254069
Registration: May 13, 2025
焦作市民康药业有限公司

Velaglucerase beta for Injection

Approval Number: 国药准字S20250020
Registration: May 13, 2025
北海康成（上海）生物科技有限公司

Composite Potassium Hydrogen Phosphate Injection

Approval Number: 国药准字H20254092
Registration: May 13, 2025
成都欣捷高新技术开发股份有限公司

Melphalan Hydrochloride for Injection

Approval Number: 国药准字H20254108
Registration: May 13, 2025
凯信远达医药（无锡）有限公司

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20254076
Registration: May 13, 2025
江苏润邦药业有限公司

Montelukast Sodium Chewable Tablets

Approval Number: 国药准字H20254126
Registration: May 13, 2025
牡丹江恒远药业股份有限公司

Mupirocin Ointment

Approval Number: 国药准字H20254083
Registration: May 13, 2025
海南紫程众投生物科技有限公司

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254160
Registration: May 13, 2025
杭州民生药业股份有限公司

Calcium Acetate Oral Solution

Approval Number: 国药准字H20254087
Registration: May 13, 2025
河北华晨药业集团有限公司

Fluvoxamine Maleate Tablets

Approval Number: 国药准字H20254152
Registration: May 13, 2025
合肥英太制药有限公司

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254142
Registration: May 13, 2025
云南先施药业有限公司

Roxadustat Capsules

Approval Number: 国药准字H20254104
Registration: May 13, 2025
重庆圣华曦药业股份有限公司

Progesterone Soft Capsules

Approval Number: 国药准字H20254090
Registration: May 13, 2025
浙江仙琚制药股份有限公司

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20254149
Registration: May 13, 2025
深圳市华生元基因工程发展有限公司

Bireociclib Tablets

Approval Number: 国药准字H20250013
Registration: May 13, 2025
轩竹生物科技股份有限公司

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254159
Registration: May 13, 2025
中润药业有限公司

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20254171
Registration: May 13, 2025
武汉维奥制药有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.